Emergence of Promising Therapies in Diabetes Mellitus

Akkati, Sindhu and Sam, Kishore Gnana and Thunga, Girish (2011) Emergence of Promising Therapies in Diabetes Mellitus. Journal of Clinical Pharmacology , 51. pp. 796-804.

PDF 22__Emergence_of_Promising_Therapies_in_DM.pdf - Published Version Restricted to Registered users only Download (258kB) | Request a copy

Abstract

Diabetes mellitus (DM) results from defects in insulin secretion (type 1) or insulin resistance (type 2). Insulin is used to manage type 1 DM, and oral hypoglycemic agents are used to manage type 2 DM. These therapies are inconsistent in maintaining glycemic control and cause some severe adverse effects such as undue weight gain and hypoglycemia. New and appropriate therapies are needed to overcome these problems. Drugs that are in the pipeline include oral insulins for type 1 DM and incretin mimetics, incretin enhancers, gastric inhibitory peptides, amylin analogues, peroxisome proliferator-activated receptor-α/γ ligands, sodium-dependent glucose transporter inhibitors, and fructose 1,6-bisphosphatase inhibitors for type 2 DM. This article describes the mechanisms of action and relative advantages and disadvantages of the promising therapies

Actions (login required)

View Item